A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer

NCT07538271 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

SCLC, Extensive Stage

Interventions

DRUG: benmelstobart
DRUG: Anlotinib
DRUG: Carboplatin or cisplatin
DRUG: Etoposide
RADIATION: Thoracic Radiotherapy

Sponsor

Yayi He

Collaborators

[object Object]